News

Using white blood cells to ferry potent cancer-killing proteins through the bloodstream virtually eliminates metastatic prostate cancer in mice, Cornell researchers have confirmed.

New protein, DWORF, stimulates a calcium-ion pump that controls muscle contraction.

A University of York spin-out backed by the Royal Academy of Engineering’s Enterprise Hub, has been awarded a £300,000 grant from the UK’s innovation agency Innovate UK.

New methodology means biological assays that once took hours could instead take minutes.

Top scientists partner to research the progression and biology of RIA diseases.

icometrix, the fast growing imaging biomarker company has closed a financing round of over €2 million.

SCIEX and Pressure BioSciences to offer complete solution for next-generation proteomics, to increase the reproducibility and depth of proteomic analysis.

With this announcement next-generation sequencing and precision medicine has evolved from research to the clinical cancer setting.

An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.

Melioidosis, a difficult to diagnose deadly bacterial disease, is likely to be present in many more countries than previously thought.